| Literature DB >> 29567223 |
Monjurul Haq1, Seul-Ki Park2, Min-Jung Kim2, Yeon-Jin Cho1, Byung-Soo Chun1.
Abstract
Omega-3 polyunsaturated fatty acids (ω-3 PUFAs) rich 2-monoacylglycerols (2-MAG), omega-3 polyunsaturated free fatty acids (ω-3 PUFFAs) concentrate, and PUFA enriched acylglycerols were prepared from salmon frame bone oil (SFBO) by enzymatic alcoholysis, urea complexation, and enzymatic esterification, respectively. The yields of 2-MAG, ω-3 PUFFAs concentrate, and PUFA enriched acylglycerols were 40.25, 16.52, and 15.65%, respectively. ω-3 PUFFAs concentrate and PUFA enriched acylglycerols showed darker red color than SFBO and 2-MAG due to aggregation of astaxanthin pigment in ω-3 PUFFAs concentrate during urea complexation. The viscosity and specific gravity of SFBO and PUFA enriched acylglycerols showed similar values whereas 2-MAG and ω-3 PUFFAs showed significantly (p < 0.05) lower values. Stability parameters like acid value, peroxide value, free fatty acid value, and p-anisidine value of SFBO and ω-3 PUFAs concentrates were within acceptable limits except extreme high acid value and free fatty acid value of ω-3 PUFFAs concentrate. Thermogravimetric analysis showed similar and higher thermal stability of SFBO and PUFA enriched acylglycerols than 2-MAG and ω-3 PUFFAs concentrate. The ω-3 PUFAs content in 2-MAG, ω-3 PUFFAs concentrate, and PUFA enriched acylglycerols was increased to 20.81, 52.96, and 51.74% respectively from 13.54% in SFBO. ω-3 PUFFAs concentrate and PUFA enriched acylglycerols showed higher DPPH and ABTS radical scavenging activity than SFBO and 2-MAG. The results obtained from this study suggest the production of PUFA enriched acylglycerols rich in ω-3 PUFAs supplements from fish oil for human and pet animals.Entities:
Keywords: 2-MAG; Comparative analysis; PUFA enriched acylglycerols; Salmon frame bone oil; ω-3 PUFFAs concentrate
Mesh:
Substances:
Year: 2017 PMID: 29567223 PMCID: PMC9322207 DOI: 10.1016/j.jfda.2017.05.006
Source DB: PubMed Journal: J Food Drug Anal Impact factor: 6.157
Fig. 1Standard curve used for the determination of astaxanthin content.
Fig. 2TLC analysis of SFBO and ω-3 PUFAs concentrates.
Fig. 3Yield of different ω-3 PUFAs concentrates. Values are the mean of 3 determinations. Different letters with the bar indicate significant differences (p < 0.05).
Physical properties and astaxanthin content of SFBO and different ω-3 PUFAs concentrates.
| Parameters | SFBO | 2-MAG | ω-3 PUFFAs | PUFA enriched acylglycerols |
|---|---|---|---|---|
| Color | ||||
| L* | 36.08a ± 0.66 | 36.02a ± 0.56 | 30.52b ± 0.11 | 29.86b ± 0.39 |
| a* | 9.06b ± 0.19 | 9.46b ± 0.22 | 12.51a ± 0.38 | 11.98a ± 0.51 |
| b* | 10.46a ± 0.17 | 8.68b ± 0.29 | 4.3c ± 0.21 | 3.33d ± 0.18 |
| Astaxanthin (μg/g) | 21.81b ± 0.70 | 21.94b ± 0.41 | 44.23a ± 0.42 | 43.66a ± 0.51 |
| Viscosity (cP) | 49.09a ± 0.67 | 39.57b ± 0.63 | 18.86c ± 0.69 | 48.88a ± 0.66 |
| Sp. gravity | 0.91a ± 0.01 | 0.90a ± 0.01 | 0.87b ± 0.01 | 0.90a ± 0.01 |
Values are means ± standard deviations (n = 3). In each row, the different superscript letters differ significantly (P < 0.05).
The L* value is the “lightness” of a sample from 0 to 100 with 100 being pure white; the a* value describes red (+) to green (−); the b* value represents yellow (+) to blue (−). cP = centipoise, 1 cP = 0.01 g per centimeter-second.
Stability properties of normal SFBO and different ω-3 PUFAs concentrates.
| Parameters | SFBO | 2-MAG | ω-3 PUFFAs | PUFA enriched acylglycerols |
|---|---|---|---|---|
| Acid value (mg KOH/g) | 7.10d ± 0.12 | 12.01b ± 0.32 | 140.45a ± 0.64 | 8.34c ± 0.32 |
| Peroxide value (meq/kg) | 1.26d ± 0.05 | 3.70a ± 0.07 | 2.08c ± 0.12 | 2.37b ± 0.10 |
| Free fatty acid value (%) | 2.37d ± 0.16 | 4.52b ± 0.09 | 81.88a ± 0.33 | 3.80c ± 0.32 |
| 6.89b ± 0.14 | 5.48c ± 0.35 | 9.06a ± 0.27 | 6.81b ± 0.16 | |
| OSI value (h) | 1.62a ± 0.10 | 1.54b ± 0.01 | – | 1.63a ± 0.1 |
Values are means ± standard deviations (n = 3). In each row, the different superscript letters differ significantly (P < 0.05).
Fig. 4The pattern of the thermal degradation of SFBO and different ω-3 PUFAs concentrates.
Fatty acid composition of SFBO and different ω-3 PUFAs concentrates.
| Sl No. | Name of fatty acids | SFBO | 2-MAG | ω-3 PUFFAs | PUFA enriched acylglycerols |
|---|---|---|---|---|---|
| 1. | Caprylic Acid (C8:0) | 1.23 | ND | ND | ND |
| 2. | Myristic Acid (C14:0) | 3.29 | ND | 0.47 | 0.45 |
| 3. | Palmitic Acid (C16:0) | 12.22 | 4.62 | ND | ND |
| 4. | Palmitoleic Acid (C16:1) | 4.13 | 3.48 | 1.35 | 1.36 |
| 5. | Stearic Acid (C18:0) | 3.53 | 0.94 | 1.35 | 1.36 |
| 6. | Oleic Acid (C18:1n9C) | 34.34 | 38.59 | 3.07 | 3.15 |
| 7. | Elaidic Acid (C18:1n9t) | 3.38 | 1.73 | 0.61 | 0.56 |
| 8. | Linoleic Acid (C18:2n6c) | 16.01 | 23.84 | 25.73 | 24.65 |
| 9. | Eicosenoic Acid (C20:1) | 3.30 | ND | 1.26 | 1.20 |
| 10. | α-Linolenic Acid (C18:3n3)/ALA | 4.00 | 8.53 | 7.41 | 7.35 |
| 11. | Eicosadienoic Acid (C20:2) | 1.66 | 1.43 | 4.06 | 4.12 |
| 12. | Behenic Acid (C22:0) | 0.43 | ND | 2.22 | 2.20 |
| 13. | Eicosatrienoic Acid (C20:3n6) | 0.36 | ND | 1.25 | 1.23 |
| 14. | Euric Acid (C22:1n9) | 0.39 | ND | 0.12 | 0.10 |
| 15. | Eicosatrienoic Acid (C20:3n3) | 0.88 | ND | 0.38 | 0.32 |
| 16. | Tricosanoic Acid (C23:0) | 0.49 | ND | 1.66 | 1.60 |
| 17. | Docosadienoic Acid (C22:2n6) | 0.91 | 0.92 | 3.34 | 3.35 |
| 18. | Eicosapentaenoic Acid (C20:5n3)/EPA | 3.93 | 2.17 | 20.51 | 20.25 |
| 19. | Nervonic Acid (C24:1) | 0.37 | ND | ND | ND |
| 20. | Docosahexaenoic Acid (C22:6n3)/DHA | 4.73 | 10.11 | 24.66 | 24.14 |
| ∑EPA + DHA | 8.66 | 12.28 | 45.17 | 44.39 | |
| ∑ω-3 PUFAs | 13.54 | 20.81 | 52.96 | 51.74 | |
| ∑ω-6 PUFAs | 17.28 | 24.76 | 30.32 | 29.23 | |
| ∑SFA | 21.19 | 5.56 | 5.70 | 5.61 |
N.B.: EPA: Eicosapentaenoic acid, DHA: Docosahexaenoic acid, PUFA: Polyunsaturated fatty acid, SFA: Saturated fatty acid, ND: Not detected.
Fig. 5Antioxidant activity of SFBO and different ω-3 PUFAs concentrates (a) DPPH radical scavenging activity (b) ABTS+ inhibition activity.